tiprankstipranks
Advertisement
Advertisement
Argenx price target raised to $1,059 from $1,007 at Evercore ISI
PremiumThe FlyArgenx price target raised to $1,059 from $1,007 at Evercore ISI
20d ago
Argenx price target raised to $1,016 from $1,013 at BofA
Premium
The Fly
Argenx price target raised to $1,016 from $1,013 at BofA
24d ago
Myles Minter Reiterates Buy as Vyvgart’s Expanded FDA Label and Attractive Valuation Support Continued Growth
Premium
Ratings
Myles Minter Reiterates Buy as Vyvgart’s Expanded FDA Label and Attractive Valuation Support Continued Growth
24d ago
Argenx price target lowered to $1,222 from $1,227 at Stifel
PremiumThe FlyArgenx price target lowered to $1,222 from $1,227 at Stifel
28d ago
Argenx Posts 63% Q1 Sales Surge as New CEO Steers Expansion of Autoimmune Portfolio
Premium
Company Announcements
Argenx Posts 63% Q1 Sales Surge as New CEO Steers Expansion of Autoimmune Portfolio
28d ago
Argenx Maintains Buy Rating on Vyvgart Momentum, Robust Profitability, and Expanding Late-Stage Pipeline
Premium
Ratings
Argenx Maintains Buy Rating on Vyvgart Momentum, Robust Profitability, and Expanding Late-Stage Pipeline
28d ago
Argenx Completes Key CIDP Switch Study, Setting Up Next Steps for Efgartigimod
PremiumCompany AnnouncementsArgenx Completes Key CIDP Switch Study, Setting Up Next Steps for Efgartigimod
2M ago
Argenx price target lowered to $1,014 from $1,060 at Oppenheimer
Premium
The Fly
Argenx price target lowered to $1,014 from $1,060 at Oppenheimer
2M ago
Argenx added to European Conviction List at Goldman Sachs
Premium
The Fly
Argenx added to European Conviction List at Goldman Sachs
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100